myeloma

Cost-effectiveness analysis of a HMGA2 prognostic test for acute myeloid leukaemia in a Canadian setting Tremblay G, Rousseau B, Marquis M, Beaubois C, Sauvageau G, H├ębert J Appl Health Econ Health Policy (2019) Economic evaluations of subcutaneously administered oncology therapies: A health technology assessment (HTA)… Read More